• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • S. O'Farrell, H. Garmo, L. Holmberg, Jan Adolfsson, P. Stattin, M. van Hemelrijck
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2015 (First Publication: 10 April 2015)
  • PURPOSE Findings on the association between risk of cardiovascular disease (CVD) and the duration and type of androgen-deprivation therapy (ADT) in men with prostate cancer (PCa) are inconsistent. Expand
  • M. van Hemelrijck, H. Garmo, +6 authors J. Adolfsson
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2010 (First Publication: 20 July 2010)
  • PURPOSE Cardiovascular disease (CVD) is a potential adverse effect of endocrine treatment (ET) for prostate cancer (PC). We investigated absolute and relative CVD risk in 76,600 patients with PCExpand
  • Cecilia Bosco, Zsolt Bosnyák, Anders Malmberg, Jan Adolfsson, Nancy L. Keating, Mieke van Hemelrijck
  • Medicine
  • European urology
  • 2015 (First Publication: 1 September 2015)
  • CONTEXT Whether androgen deprivation therapy (ADT) for men with prostate cancer (PCa) increases the risk of cardiovascular disease (CVD) remains controversial. Pooled analyses using data fromExpand
  • Mieke van Hemelrijck, Lars H Holmberg, +5 authors Ingmar Jungner
  • Medicine
  • Cancer Epidemiology, Biomarkers & Prevention
  • 2011 (First Publication: 4 February 2011)
  • Objective: To study levels of C-reactive protein (CRP) and leukocytes, as inflammatory markers, in the context of cancer risk. Methods: From the Apolipoprotein MOrtality RISk (AMORIS) study, weExpand